NCT02457897View on ClinicalTrials.gov

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 17, 2015

Primary Completion Date

September 18, 2018

Study Completion Date

September 18, 2018

Conditions

Insulin ResistanceDiabetes MellitusAbnormal Glucose Metabolism

Interventions

DRUG

Liothyronine

Oral supplement given every 8 hours

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT02457897 - Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations | Biotech Hunter | Biotech Hunter